New drug trial aims to rescue failing livers
NCT ID NCT05689645
Summary
This study is testing a new drug called F573 for people with serious liver injury or failure. It aims to see if the drug is safe and can help control liver damage. About 97 participants will receive either the drug or a placebo injection daily for up to 28 days, along with standard care. Researchers will closely monitor liver health, side effects, and survival for 90 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ON CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Southwest Medical University
RECRUITINGLuzhou, Sichuan, China
Contact
-
Beijing You 'an Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
Contact
-
First Hospital of Jilin University
RECRUITINGChangchun, Jilin, China
Contact
-
Heze Municipal Hospital
RECRUITINGHeze, Shandong, China
Contact
-
Hunan Medical College General Hospital (formerly Huaihua City First People's Hospital)
RECRUITINGHuaihua, Hunan, China
Contact
-
Pingxiang Second People's Hospital
RECRUITINGPingxiang, Jiangxi P, China
Contact
-
Qingyuan People's Hospital (Sixth Affiliated Hospital of Guangzhou Medical University)
RECRUITINGQingyuan, Guangdong, China
Contact
-
Shanxi Bethune Hospital
RECRUITINGTaiyuan, Shanxi, China
Contact
-
Shiyan City Taihe Hospital
RECRUITINGShiyan, Hubei, China
Contact
-
The Affiliated Hospital of Binzhou Medical University
RECRUITINGBinzhou, Shandong, China
Contact
Conditions
Explore the condition pages connected to this study.